Migraine
Conditions
Interventions
Apply the CGS-1 for forehead for 2 hours.
Apply the placebo for forehead for 2 hours.
Sponsors
Kao Corporation
Tokyo Clinic
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Women aged 20-49. 2)Subjects with migraine without aura experience three to five migraine per month. 3)Subjects with lucidity and no intellectual disability can communicate. 4)Written informed consent. 5)If migraine and tension type headache are merged, the subjects can distinguish between the two.
Exclusion criteria
Exclusion criteria: 1)Subjects with migraine with aura 2)Subjects with the headache without migraine 3)Subjects with taking triptan medicine. 4)Subjects with the hemicrania continua. 5)Subjects with pregnancies and lactations. 6)Subjects with atopic dermatitis. 7)Subjects with vulnerable to skin irritation by menthol or alcohol. 8)Subjects deemed inappropriate to participate in this study by the principle investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in NRS (Numerical Rating Scale) from the start of the test to 30 minutes later. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Change in NRS (Numerical Rating Scale) at 60 minutes, 120 minutes and 180 minutes after the start of the test. 2)Changes in daily disability assessment HIT (Headache Impact Test) - 6 | — |
Countries
Japan
Contacts
Public ContactNobuyasu Kimura
Tokyo Clinic Pain Clinic of Internal Medicines
Outcome results
None listed